查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604768

免疫检测自动分析仪市场：按产品、应用和最终用户划分 - 全球预测 2025-2030 年

Automated Immunoassay Analyzers Market by Product (Chemiluminescence, Enzyme-Linked Fluorescent System, Immunofluorescence), Application (Allergy Testing, Chronic Diseases, Drug Monitoring), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年免疫检测自动化分析仪市值为118.2亿美元，预计2024年将达到126.3亿美元，复合年增长率为6.92%，到2030年将达到188.9亿美元。

免疫检测自动分析仪是先进的仪器，旨在透过免疫测量技术自动检测和定量样本中的特定生物分子或分析物。这项需求源自于临床检测、製药、生物技术等领域对高通量、准确、快速诊断结果的需求。主要应用范围广泛，包括疾病诊断、药物监测、癌症生物标记检测等，主要终端使用者为医院、研究机构和诊断实验室。市场成长是由技术进步、慢性病增加以及实验室越来越多地采用自动化来提高效率和减少错误所推动的。机会在于新兴市场、个人化医疗以及与人工智慧的整合以改善资料解释。公司可以透过推动创新来利用这些优势，提高分析仪器的通量、灵敏度和整合能力。然而，高昂的初始投资成本、严格的监管以及对高技能人才的需求等挑战可能会阻碍市场扩张。智慧财产权问题和来自分子诊断等替代诊断方法的竞争也构成了威胁。扩大测试参数的检测开发和支援现场护理的设备小型化等创新对该行业有利。此外，探索具有成本效益的多功能分析仪可以开闢新的市场渗透途径。自动化免疫检测市场呈现出动态的特点，其特点是快速的技术创新、市场竞争和改善患者治疗结果的动力。因此，在研发、策略伙伴关係和监管核准的持续努力对于维持我们的竞争优势至关重要。公司还应该专注于将其地理足迹扩展到实验室基础设施不断发展、消费群随着医疗保健支出不断增长而迅速增长的新兴国家。透过解决这些领域，自动化免疫检测领域的公司可以克服挑战并抓住成长机会。

主要市场统计
基准年[2023] 118.2亿美元
预测年份 [2024] 126.3亿美元
预测年份 [2030] 188.9亿美元
复合年增长率（%） 6.92%

市场动态：快速发展的自动免疫检测分析仪市场的关键市场洞察

供需的动态交互作用正在改变免疫检测自动分析仪市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 世界各地慢性病和感染疾病的流行不断扩大
    • 快速转向实验室自动化
    • 提高早期诊断和治疗意识
  • 市场限制因素
    • 与自动化免疫检测分析仪相关的高成本和预算限制
  • 市场机会
    • 将新技术整合到自动免疫检测分析仪中
    • 推出先进的免疫检测分析仪，提升测试性能
  • 市场挑战
    • 缺乏训练有素且经验丰富的专业人员

波特五力：驾驭免疫检测自动分析仪市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解免疫检测自动分析仪市场的外部影响

外部宏观环境因素在塑造免疫检测自动分析仪市场的性能动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解免疫检测自动分析仪市场竞争状况

免疫检测自动分析仪市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵免疫检测自动分析仪市场供应商绩效评估

FPNV定位矩阵是评估免疫检测自动化分析仪市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划免疫检测自动分析仪市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，免疫检测自动分析仪市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和感染疾病的盛行率正在增加。
      • 快速过渡到临床实验室自动化
      • 提高早期诊断和治疗意识
    • 抑制因素
      • 自动化免疫检测分析仪的高成本和预算限制
    • 机会
      • 自动化免疫检测分析仪中新技术的集成
      • 引进先进的免疫检测分析仪以提高实验室性能
    • 任务
      • 缺乏训练有素且经验丰富的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章免疫检测自动分析仪市场：副产品

  • 化学冷光
  • 酵素连结萤光系统
  • 萤光
  • 免疫检测

第七章免疫检测自动分析仪市场：依应用分类

  • 过敏测试
  • 慢性病
  • 药物监测
  • 内分泌学
  • 感染疾病

第八章免疫检测自动分析仪市场：依最终用户分类

  • 学术研究所
  • 生物技术和製药公司
  • 诊断测试实验室
  • 医院

第九章 北美和南美自动化免疫检测分析仪市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太免疫检测自动分析仪市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲自动化免疫检测分析仪市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Arlington Scientific, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biobase Biodusty（Shandong）, Co., Ltd.
  • bioMerieux SA
  • Carolina Liquid Chemistries Corp.
  • Charles River Laboratories
  • Chengdu Vacure Biotechnology Co., Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Getein Biotech, Inc.
  • Hipro Biotechnology Co., Ltd.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation by DiaSorin Company
  • Medline Industries, LP
  • Meril Life Sciences Pvt. Ltd.
  • PerkinElmer, Inc.
  • PHC Europe BV
  • Qiagen NV
  • Randox Laboratories
  • Siemens Healthineers
  • Sysmex Corporation
Product Code: MRR-FF012EDC38AA

The Automated Immunoassay Analyzers Market was valued at USD 11.82 billion in 2023, expected to reach USD 12.63 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 18.89 billion by 2030.

Automated Immunoassay Analyzers are sophisticated instruments designed to automate the detection and quantification of specific biomolecules or analytes within a sample through immunoassay techniques. Their necessity arises from the demand for high-throughput, accurate, and rapid diagnostic results in fields like clinical laboratories, pharmaceuticals, and biotechnology. The primary application spans disease diagnostics, drug monitoring, and cancer biomarkers detection, while key end-users include hospitals, research institutes, and diagnostic laboratories. Market growth is driven by technological advancements, rising incidences of chronic diseases, and increased adoption of automation in laboratories to improve efficiency and reduce errors. Opportunities lie in emerging markets, personalized medicine, and integration with AI for improved data interpretation. Companies can capitalize on these by fostering innovations that enhance analyzer throughput, sensitivity, and integration capabilities. However, challenges such as high initial investment costs, stringent regulations, and the need for highly skilled personnel may hinder market expansion. Intellectual property issues and competition from alternative diagnostic methods like molecular diagnostics also pose threats. The industry can benefit from innovations in assay development to broaden testing parameters, and in miniaturization of devices to cater to point-of-care settings. Moreover, research into cost-effective, multifunctional analyzers could open new avenues for market penetration. The automated immunoassay market exhibits a dynamic nature characterized by rapid technological innovation, competitive pricing, and a push for improved patient outcomes. As such, continuous engagement in R&D, strategic partnerships, and acquisition of regulatory approvals are crucial for sustaining competitive advantage. Companies should also focus on expanding their geographical footprint to emerging economies where laboratory infrastructure is evolving, offering a burgeoning consumer base with rising healthcare expenditure. By addressing these areas, businesses in the automated immunoassay sector can navigate challenges and harness opportunities for growth.

KEY MARKET STATISTICS
Base Year [2023] USD 11.82 billion
Estimated Year [2024] USD 12.63 billion
Forecast Year [2030] USD 18.89 billion
CAGR (%) 6.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic and infectious diseases across the globe
    • Rapid shift towards clinical laboratory automation
    • Surging awareness of early diagnosis and treatments
  • Market Restraints
    • Associated high cost of automated immunoassay analyzers and budget constraints
  • Market Opportunities
    • Integration of novel technologies in automated immunoassay analyzers
    • Emergence of advanced immunoassay analyzer for enhanced laboratory performance
  • Market Challenges
    • Lack of trained and experienced professionals

Porter's Five Forces: A Strategic Tool for Navigating the Automated Immunoassay Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Immunoassay Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Immunoassay Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Immunoassay Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Immunoassay Analyzers Market

A detailed market share analysis in the Automated Immunoassay Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Immunoassay Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Immunoassay Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Immunoassay Analyzers Market

A strategic analysis of the Automated Immunoassay Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arlington Scientific, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biobase Biodusty(Shandong), Co., Ltd., bioMerieux SA, Carolina Liquid Chemistries Corp., Charles River Laboratories, Chengdu Vacure Biotechnology Co., Ltd., Danaher Corporation, F. Hoffmann-La Roche AG, Getein Biotech, Inc., Hipro Biotechnology Co., Ltd., Hitachi, Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, Medline Industries, LP, Meril Life Sciences Pvt. Ltd., PerkinElmer, Inc., PHC Europe B.V., Qiagen N.V., Randox Laboratories, Siemens Healthineers, and Sysmex Corporation.

Market Segmentation & Coverage

This research report categorizes the Automated Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Chemiluminescence, Enzyme-Linked Fluorescent System, Immunofluorescence, and Radioimmunoassay.
  • Based on Application, market is studied across Allergy Testing, Chronic Diseases, Drug Monitoring, Endocrinology, and Infectious Diseases.
  • Based on End-User, market is studied across Academic Research Institutes, Biotech & Pharma Companies, Diagnostic Test Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic and infectious diseases across the globe
      • 5.1.1.2. Rapid shift towards clinical laboratory automation
      • 5.1.1.3. Surging awareness of early diagnosis and treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Associated high cost of automated immunoassay analyzers and budget constraints
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of novel technologies in automated immunoassay analyzers
      • 5.1.3.2. Emergence of advanced immunoassay analyzer for enhanced laboratory performance
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of trained and experienced professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Automated Immunoassay Analyzers Market, by Product

  • 6.1. Introduction
  • 6.2. Chemiluminescence
  • 6.3. Enzyme-Linked Fluorescent System
  • 6.4. Immunofluorescence
  • 6.5. Radioimmunoassay

7. Automated Immunoassay Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Allergy Testing
  • 7.3. Chronic Diseases
  • 7.4. Drug Monitoring
  • 7.5. Endocrinology
  • 7.6. Infectious Diseases

8. Automated Immunoassay Analyzers Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic Research Institutes
  • 8.3. Biotech & Pharma Companies
  • 8.4. Diagnostic Test Laboratories
  • 8.5. Hospitals

9. Americas Automated Immunoassay Analyzers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Automated Immunoassay Analyzers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Automated Immunoassay Analyzers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Arlington Scientific, Inc.
  • 3. Becton Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Biobase Biodusty(Shandong), Co., Ltd.
  • 6. bioMerieux SA
  • 7. Carolina Liquid Chemistries Corp.
  • 8. Charles River Laboratories
  • 9. Chengdu Vacure Biotechnology Co., Ltd.
  • 10. Danaher Corporation
  • 11. F. Hoffmann-La Roche AG
  • 12. Getein Biotech, Inc.
  • 13. Hipro Biotechnology Co., Ltd.
  • 14. Hitachi, Ltd.
  • 15. Illumina, Inc.
  • 16. Laboratory Corporation of America Holdings
  • 17. Luminex Corporation by DiaSorin Company
  • 18. Medline Industries, LP
  • 19. Meril Life Sciences Pvt. Ltd.
  • 20. PerkinElmer, Inc.
  • 21. PHC Europe B.V.
  • 22. Qiagen N.V.
  • 23. Randox Laboratories
  • 24. Siemens Healthineers
  • 25. Sysmex Corporation

LIST OF FIGURES

  • FIGURE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOMATED IMMUNOASSAY ANALYZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED FLUORESCENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DIAGNOSTIC TEST LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023